Cardiovascular Systems, Inc. (Nasdaq: CSII):
•Revenues of $25.3 million rose 28 percent over the fiscal 2012 second quarter, and 9 percent sequentially over the fiscal 2013 first quarter?Stealth 360°® revenues increased to 93 percent of total device revenues ?Office-based lab revenues continued to grow at a double-digit consecutive quarter rate
